These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35184747)

  • 1. Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations.
    Liu W; Jiang Q; Sun C; Liu S; Zhao Z; Wu D
    BMC Cancer; 2022 Feb; 22(1):192. PubMed ID: 35184747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying a cervical cancer survival signature based on mRNA expression and genome-wide copy number variations.
    Li N; Yu K; Lin Z; Zeng D
    Exp Biol Med (Maywood); 2022 Feb; 247(3):207-220. PubMed ID: 34674573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
    Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
    BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data.
    Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J
    J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    Mo W; Ding Y; Zhao S; Zou D; Ding X
    PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
    Zhen Z; Shen Z; Hu Y; Sun P
    Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
    Zhang Y; Lu H; Zhang J; Wang S
    Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma.
    Li Y; Lu S; Lan M; Peng X; Zhang Z; Lang J
    J Transl Med; 2020 Jun; 18(1):223. PubMed ID: 32503630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer.
    Hu W; Li M; Zhang Q; Liu C; Wang X; Li J; Qiu S; Li L
    J Ovarian Res; 2021 Aug; 14(1):103. PubMed ID: 34364397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
    Zengin T; Önal-Süzek T
    BMC Bioinformatics; 2020 Sep; 21(Suppl 14):368. PubMed ID: 32998690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
    Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer.
    Lu X; Li R; Ying Y; Zhang W; Wang W
    J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.
    Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J
    Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-Related Four-lncRNA Signature for Patients with Cervical Cancer.
    Zheng J; Cao B; Zhang X; Niu Z; Tong J
    Biomed Res Int; 2020; 2020():3641231. PubMed ID: 33274204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of potential mRNA- microRNA- long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer.
    Wang J; Zhang C
    Bioengineered; 2021 Dec; 12(1):898-913. PubMed ID: 33682613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.